Filing Details
BIOFORCE NANOSCIENCES HOLDINGS, INC. (OTC:BFNH) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
8k filedOTC:BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) Reports Material Event to SEC
BIOFORCE NANOSCIENCES HOLDINGS, INC. (OTC:BFNH) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
At publication ·
What changed
BIOFORCE NANOSCIENCES HOLDINGS, INC. (OTC:BFNH) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) filed a Form 8-K with the SEC on August 18, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $3.84 with a market capitalization of $17.8 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
BIOFORCE NANOSCIENCES HOLDINGS, INC.'s stock currently trades at $3.84 with a market capitalization of $17.8M. The Consumer Defensive company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for BIOFORCE NANOSCIENCES HOLDINGS, INC.'s stock.
All SEC filings for BIOFORCE NANOSCIENCES HOLDINGS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BFNH Stock Page
Frequently Asked Questions
Where can I read BFNH's SEC filings?
Browse all filings on our BFNH SEC filings page.
What types of SEC filings does BIOFORCE NANOSCIENCES HOLDINGS, INC. file?
Public companies like BIOFORCE NANOSCIENCES HOLDINGS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.